Vaccines: A Molecular View
... • Inactivated virus Vaccine • Traditional flu shots are “trivalent” – i.e. protects against 2 influenza A and 1 influenza B virus • Also available Quadrivalent flu vaccine – protects against 2 influenza A and 2 influenza B virus http://www.cdc.gov/flu/protect/keyfacts.htm ...
... • Inactivated virus Vaccine • Traditional flu shots are “trivalent” – i.e. protects against 2 influenza A and 1 influenza B virus • Also available Quadrivalent flu vaccine – protects against 2 influenza A and 2 influenza B virus http://www.cdc.gov/flu/protect/keyfacts.htm ...
Vaccines at My Age? - Aimee Armour
... Tdap is recommended for all adults who come in contact with young infants less than 12 months old. Other adults are recommended to receive a one-time dose of the Tdap vaccine. After your initial dose of Tdap, you’ll need the Td booster every 10 years. But you don’t need to wait to get the Tdap vacci ...
... Tdap is recommended for all adults who come in contact with young infants less than 12 months old. Other adults are recommended to receive a one-time dose of the Tdap vaccine. After your initial dose of Tdap, you’ll need the Td booster every 10 years. But you don’t need to wait to get the Tdap vacci ...
Ava`s Teach a Technology Speech PowerPoint
... Berman, A., Budnick, L. D., & Imtiaz, M.A. (2016). Influenza immunization among resident physicians in an urban teaching hospital. American Journal of Infection Control, 44, 491-493. Bernstein, H., & Starke, J. (2010). Recommendation for Mandatory Influenza of All Health Care Personnel. Pediatrics, ...
... Berman, A., Budnick, L. D., & Imtiaz, M.A. (2016). Influenza immunization among resident physicians in an urban teaching hospital. American Journal of Infection Control, 44, 491-493. Bernstein, H., & Starke, J. (2010). Recommendation for Mandatory Influenza of All Health Care Personnel. Pediatrics, ...
Influenza
... The double truth about influenza: mild and severe disease • Most cases cannot be distinguished from a common cold • About 25% have the classic flu presentation.. • Influenza is, by far and away, the most common cause of vaccine preventable disease AND DEATH in Australia • The annual number of dea ...
... The double truth about influenza: mild and severe disease • Most cases cannot be distinguished from a common cold • About 25% have the classic flu presentation.. • Influenza is, by far and away, the most common cause of vaccine preventable disease AND DEATH in Australia • The annual number of dea ...
Key References
... Edward J. Septimus, Michael L. Tapper, David J. Weber, (October 2010). Revised SHEA Position Paper: Influenza Vaccination of Healthcare Personnel. Infection Control and Hospital Epidemiology, Vol. 31, No. ...
... Edward J. Septimus, Michael L. Tapper, David J. Weber, (October 2010). Revised SHEA Position Paper: Influenza Vaccination of Healthcare Personnel. Infection Control and Hospital Epidemiology, Vol. 31, No. ...
PDF file - Halton Region
... people who care for or will be visiting persons with severe immune compromising conditions (bone marrow transplant recipient in isolation) within 2 weeks of receiving FluMist® people who have taken antiviral medication against influenza in the last 48 hours people who have developed Guillain-Barré s ...
... people who care for or will be visiting persons with severe immune compromising conditions (bone marrow transplant recipient in isolation) within 2 weeks of receiving FluMist® people who have taken antiviral medication against influenza in the last 48 hours people who have developed Guillain-Barré s ...
Influenza in Health Care Settings (PDF)
... The U.S. Food and Drug Administration recently approved the neruaminidiase inhibitor peramivir (Rapivab) to treat influenza infection in adults 18 and older. Peramivir is the first neuraminidase inhibitor approved for intravenous (IV) administration. As before, oseltamivir (Tamiflu) and zanamivir (R ...
... The U.S. Food and Drug Administration recently approved the neruaminidiase inhibitor peramivir (Rapivab) to treat influenza infection in adults 18 and older. Peramivir is the first neuraminidase inhibitor approved for intravenous (IV) administration. As before, oseltamivir (Tamiflu) and zanamivir (R ...
Read More
... in Mexico, offering pure and effective protection against the flu. Other influenza vaccines are made using 70 year old egg-based technology that is subject to mutations. The Mexican authorities also approved a 1 year shelf life and the use of the Flublok trade name. “We are very pleased with the rap ...
... in Mexico, offering pure and effective protection against the flu. Other influenza vaccines are made using 70 year old egg-based technology that is subject to mutations. The Mexican authorities also approved a 1 year shelf life and the use of the Flublok trade name. “We are very pleased with the rap ...
Name: Per: A Case Study Involving Influenza and the Influenza
... 5. Karen described the upper respiratory infection that she suffered last year and thinks that her well-being is a matter of fate. How many infectious agents cause URI? How can these infections be prevented? How can they be treated? ...
... 5. Karen described the upper respiratory infection that she suffered last year and thinks that her well-being is a matter of fate. How many infectious agents cause URI? How can these infections be prevented? How can they be treated? ...
Flu - PassportHealthTexas.com
... Flu Influenza (flu) is a respiratory disease caused by influenza virus infection. The types or strains, of influenza virus that cause illness may change from year to year, or even within the same year. People who get flu may have fever, chills, headache, dry cough, and muscle aches, and may be sick ...
... Flu Influenza (flu) is a respiratory disease caused by influenza virus infection. The types or strains, of influenza virus that cause illness may change from year to year, or even within the same year. People who get flu may have fever, chills, headache, dry cough, and muscle aches, and may be sick ...